Proteomics Market Growth Accelerated by Rising R&D Spending and Greater Government Funding for Proteomics Research

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Proteomics Market Size, Share & Trends Analysis Report By Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service, (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Labs, Biopharma), Region, Market Outlook And Industry Analysis 2031"

The global proteomics market is estimated to reach over USD 110.25 billion by 2031, exhibiting a CAGR of 13.84% during the forecast period.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1896

Proteomics is a scientific approach used to identify disease-associated proteins and analyze their synthesis, function, and structure. It plays a critical role in diagnosing and identifying prognostic indicators for diseases such as cancer, viral infections, malaria, and tuberculosis. In the pharmaceutical sector, proteomics is utilized to assess drug efficacy and toxicity. The increasing prevalence of target diseases, growing demand for personalized medicine, and advancements in diagnostic techniques for targeted therapies are key factors driving the growth of the proteomics industry. Furthermore, the global market is expected to expand significantly in the coming years, supported by technological innovations, increased research funding, rising healthcare expenditures, growing demand for precision medicine, and a higher incidence of genetic disorders. The increasing prevalence of chronic diseases, including cancer, cardiovascular diseases (CVDs), respiratory conditions, and chronic kidney disease (CKD), is also anticipated to contribute to the market's expansion.

List of Prominent Players in the Proteomics Market:
• Agilent Technologies, Inc.
• Biognosys Ag
• Biomax Informatics Ag
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Charles River Laboratories
• Creative Proteomics
• Danaher
• Eurofins Scientific
• Fios Genomics
• Genewiz
• Horiba Corporation
• Illumina, Inc.
• Macrogen Inc.
• Medgenome Labs
• Merck Kgaa
• Perkinelmer, Inc.
• Promega Corporation
• Protagene Protein Services
• Qiagen N.V.
• Sengenics
• Shimadzu Corporation
• Thermo Fisher Scientific Inc.
• Waters Corporation
• Wuxi Nextcode

Market Dynamics:
Drivers-
The growth of the proteomics market is primarily driven by the increasing demand for personalized medicine, rising investment in research and development, enhanced government funding for proteomics, and ongoing technological advancements. Proteomics is rapidly emerging as a critical field in disease diagnosis. Additional factors contributing to market growth include the expanding scope of research and development in proteomics and the increasing demand for tailored therapeutics. Leading market players are expected to intensify their efforts in developing innovative and effective pharmaceutical products and diagnostic tools, which will likely drive market growth over the forecast period. Furthermore, advancements in cancer liquid biopsy research are facilitating the adoption of these innovative applications and methodologies. Strategic corporate initiatives are also anticipated to support industry expansion in the coming years.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Challenges:
Data comparability in proteomics research is often hindered by the lack of standardized methodologies, reference materials, and quality control measures across different platforms and laboratories, which restricts the overall progress of the field. Addressing these limitations and ensuring the effective application of proteomics research in areas such as personalized medicine and drug discovery will require coordinated efforts among researchers, technology developers, regulatory bodies, and funding agencies. Additionally, validating biomarkers identified through proteomics research remains a significant challenge. The validation process demands large-scale clinical trials and the involvement of multiple stakeholders, making it both time-intensive and costly.

Regional Trends:
The North American proteomics market is anticipated to secure a significant market share, driven by extensive research on next-generation pharmaceuticals and the continuous expansion of the field. Numerous protein-based therapies are being explored through clinical trials for the treatment of cancer, immune system disorders, infections, age-related diseases, and other health conditions. The United States remains at the forefront of proteomics research. Similarly, Europe holds a substantial share of the market, supported by strong government funding and an increasing number of cancer research initiatives. The high concentration of manufacturers specializing in tailored therapeutics, coupled with rising incidences of cancer and other related diseases, is further driving market growth in the region.

Recent Developments:
• In June 2021, Bruker Corp. introduced the two new times TOF instruments. It makes new techniques and applications possible, including unbiased and in-depth multi-omics biomarker identification and epi proteomics/PTM characterization.
• In May 2020 saw the adoption of the MS approach by researchers from the University of Surrey to hasten and support the development of the COVID-19 vaccine. Microarray usage is expected to rise across various applications, supporting industry expansion.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1896

Segmentation of Proteomics Market-
By Product-
• Spectroscopy
o Mass Spectrometry
o NMR Spectroscopy
o CD Spectroscopy
• Chromatography
o HPLC Chromatography
o Ion Chromatography
o Affinity Chromatography
o Superficial Chromatography
• Electrophoresis
o Gel Electrophoresis
o Capillary Electrophoresis
• Protein Microarrays
o Biochips
o Microarray Instruments
• X-Ray Crystallography
• Surface Plasmon Resonance
• Protein Fractionation
• Other Technologies
By Regents
• Immunoassay Reagents
• Spectroscopy Reagents
• Chromatography Reagents
• Protein Microarray Reagents
• X-Ray Crystallography Reagents
• Electrophoresis Reagents
• Protein Fractionation Reagents
• Other Reagents (Edman's reagent, enzymes, cross-linking agents)
By Software & Services
• Core Proteomics Services
• Bioinformatics Software & Services
By Application-
• Clinical Diagnostic
• Drug Discovery & Development
• Others
By End users
• Hospitals
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies
• Academic Research Laboratories
• Other End Users
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.